Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional versus systemic methotrexate for lichen planopilaris
IRCT20150706023081N6Phase 3Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of methotrexate in lichen planopilaris (LPP) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: LPPAI score, Photography and 1 more. Started Oct 2026; status: recruiting.
02
Drugs
methotrexate
03
Conditions
lichen planopilaris (LPP)
Beyond the preview
Go deeper on IRCT20150706023081N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150706023081N6.